Report cover image

Kidney Fibrosis Treatment Global Market Report 2025

Published Jul 01, 2025
Length 175 Pages
SKU # BRC20148717

Description

Kidney Fibrosis Treatment Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on kidney fibrosis treatment market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase
  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as conflict, pandemic and recovery, inflation and interest rate environment and the 2nd Trump presidency.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.
Description:

Where is the largest and fastest growing market for kidney fibrosis treatment ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward? The kidney fibrosis treatment market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market’s historic and forecast market growth by geography.
  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:
  • The forecasts are made after considering the major factors currently impacting the market. These include the Russia-Ukraine war, rising inflation, higher interest rates, and the legacy of the COVID-19 pandemic.
  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth. It covers the growth trajectory of COVID-19 for all regions, key developed countries and major emerging markets.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.
Scope

Markets Covered:1) By Treatment Type: Angiotensin-Converting Enzyme (Ace) Inhibitors; Angiotensin Ii Receptor Blockers (Arbs); Pirfenidone; Renin Inhibitors; Vasopeptidase Inhibitors; Other Treatment Types

2) By Diagnosis: Blood Tests; Urine Tests; Imaging Tests; Kidney Biopsy

3) By Application: Chronic Kidney Diseases; Kidney Cancer Treatment; Other Applications

4) By End-User: Clinics; Research Center; Hospitals

Subsegments:

1) By Angiotensin-Converting Enzyme (Ace) Inhibitors: Enalapril; Captopri; Lisinopril; Ramipril

2) By Angiotensin Ii Receptor Blockers (Arbs): Losartan; Telmisartan; Valsartan; Irbesartan

3) By Pirfenidone: Branded Pirfenidone; Generic Pirfenidone

4) By Renin Inhibitors: Aliskiren; Experimental Renin Inhibitors

5) By Vasopeptidase Inhibitors: Omapatrilat; Sampatrilat

6) By Other Treatment Types: Anti-Inflammatory Agents; Stem Cell Therapy; Antifibrotic Agents Under Clinical Trials; Gene Therapy

Companies Mentioned: F. Hoffman-La Roche Ltd.; Merck & Co. Inc.; Bayer AG; AstraZeneca PLC; Cara Therapeutics Inc.

Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain

Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa

Time series: Five years historic and ten years forecast.

Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,

Data segmentations: country and regional historic and forecast data, market share of competitors, market segments.

Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.

Delivery Format: PDF, Word and Excel Data Dashboard.

Please Note: Report will be updated with the latest data and delivered to you within 3-5 working days of order.

Table of Contents

175 Pages
1. Executive Summary
2. Kidney Fibrosis Treatment Market Characteristics
3. Kidney Fibrosis Treatment Market Trends And Strategies
4. Kidney Fibrosis Treatment Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market
5. Global Kidney Fibrosis Treatment Growth Analysis And Strategic Analysis Framework
5.1. Global Kidney Fibrosis Treatment PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
5.2. Analysis Of End Use Industries
5.3. Global Kidney Fibrosis Treatment Market Growth Rate Analysis
5.4. Global Kidney Fibrosis Treatment Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
5.5. Global Kidney Fibrosis Treatment Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
5.6. Global Kidney Fibrosis Treatment Total Addressable Market (TAM)
6. Kidney Fibrosis Treatment Market Segmentation
6.1. Global Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Angiotensin-Converting Enzyme (Ace) Inhibitors
Angiotensin Ii Receptor Blockers (Arbs)
Pirfenidone
Renin Inhibitors
Vasopeptidase Inhibitors
Other Treatment Types
6.2. Global Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Blood Tests
Urine Tests
Imaging Tests
Kidney Biopsy
6.3. Global Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Chronic Kidney Diseases
Kidney Cancer Treatment
Other Applications
6.4. Global Kidney Fibrosis Treatment Market, Segmentation By End-User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Clinics
Research Center
Hospitals
6.5. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin-Converting Enzyme (Ace) Inhibitors, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Enalapril
Captopri
Lisinopril
Ramipril
6.6. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Angiotensin Ii Receptor Blockers (Arbs), By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Losartan
Telmisartan
Valsartan
Irbesartan
6.7. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Pirfenidone, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Branded Pirfenidone
Generic Pirfenidone
6.8. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Renin Inhibitors, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Aliskiren
Experimental Renin Inhibitors
6.9. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Vasopeptidase Inhibitors, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Omapatrilat
Sampatrilat
6.10. Global Kidney Fibrosis Treatment Market, Sub-Segmentation Of Other Treatment Types, By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
Anti-Inflammatory Agents
Stem Cell Therapy
Antifibrotic Agents Under Clinical Trials
Gene Therapy
7. Kidney Fibrosis Treatment Market Regional And Country Analysis
7.1. Global Kidney Fibrosis Treatment Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
7.2. Global Kidney Fibrosis Treatment Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8. Asia-Pacific Kidney Fibrosis Treatment Market
8.1. Asia-Pacific Kidney Fibrosis Treatment Market Overview
Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
8.2. Asia-Pacific Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.3. Asia-Pacific Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
8.4. Asia-Pacific Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
9. China Kidney Fibrosis Treatment Market
9.1. China Kidney Fibrosis Treatment Market Overview
9.2. China Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.3. China Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
9.4. China Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
10. India Kidney Fibrosis Treatment Market
10.1. India Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.2. India Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
10.3. India Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11. Japan Kidney Fibrosis Treatment Market
11.1. Japan Kidney Fibrosis Treatment Market Overview
11.2. Japan Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.3. Japan Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
11.4. Japan Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12. Australia Kidney Fibrosis Treatment Market
12.1. Australia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.2. Australia Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
12.3. Australia Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13. Indonesia Kidney Fibrosis Treatment Market
13.1. Indonesia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.2. Indonesia Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
13.3. Indonesia Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14. South Korea Kidney Fibrosis Treatment Market
14.1. South Korea Kidney Fibrosis Treatment Market Overview
14.2. South Korea Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.3. South Korea Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
14.4. South Korea Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15. Western Europe Kidney Fibrosis Treatment Market
15.1. Western Europe Kidney Fibrosis Treatment Market Overview
15.2. Western Europe Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.3. Western Europe Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
15.4. Western Europe Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16. UK Kidney Fibrosis Treatment Market
16.1. UK Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.2. UK Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
16.3. UK Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17. Germany Kidney Fibrosis Treatment Market
17.1. Germany Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.2. Germany Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
17.3. Germany Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18. France Kidney Fibrosis Treatment Market
18.1. France Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.2. France Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
18.3. France Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19. Italy Kidney Fibrosis Treatment Market
19.1. Italy Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.2. Italy Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
19.3. Italy Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20. Spain Kidney Fibrosis Treatment Market
20.1. Spain Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.2. Spain Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
20.3. Spain Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21. Eastern Europe Kidney Fibrosis Treatment Market
21.1. Eastern Europe Kidney Fibrosis Treatment Market Overview
21.2. Eastern Europe Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.3. Eastern Europe Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
21.4. Eastern Europe Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22. Russia Kidney Fibrosis Treatment Market
22.1. Russia Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.2. Russia Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
22.3. Russia Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23. North America Kidney Fibrosis Treatment Market
23.1. North America Kidney Fibrosis Treatment Market Overview
23.2. North America Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.3. North America Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
23.4. North America Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24. USA Kidney Fibrosis Treatment Market
24.1. USA Kidney Fibrosis Treatment Market Overview
24.2. USA Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.3. USA Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
24.4. USA Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25. Canada Kidney Fibrosis Treatment Market
25.1. Canada Kidney Fibrosis Treatment Market Overview
25.2. Canada Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.3. Canada Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
25.4. Canada Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26. South America Kidney Fibrosis Treatment Market
26.1. South America Kidney Fibrosis Treatment Market Overview
26.2. South America Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.3. South America Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
26.4. South America Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27. Brazil Kidney Fibrosis Treatment Market
27.1. Brazil Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.2. Brazil Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
27.3. Brazil Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28. Middle East Kidney Fibrosis Treatment Market
28.1. Middle East Kidney Fibrosis Treatment Market Overview
28.2. Middle East Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.3. Middle East Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
28.4. Middle East Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29. Africa Kidney Fibrosis Treatment Market
29.1. Africa Kidney Fibrosis Treatment Market Overview
29.2. Africa Kidney Fibrosis Treatment Market, Segmentation By Treatment Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.3. Africa Kidney Fibrosis Treatment Market, Segmentation By Diagnosis, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
29.4. Africa Kidney Fibrosis Treatment Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
30. Kidney Fibrosis Treatment Market Competitive Landscape And Company Profiles
30.1. Kidney Fibrosis Treatment Market Competitive Landscape
30.2. Kidney Fibrosis Treatment Market Company Profiles
30.2.1. F. Hoffman-La Roche Ltd. Overview, Products and Services, Strategy and Financial Analysis
30.2.2. Merck & Co. Inc. Overview, Products and Services, Strategy and Financial Analysis
30.2.3. Bayer AG Overview, Products and Services, Strategy and Financial Analysis
30.2.4. AstraZeneca PLC Overview, Products and Services, Strategy and Financial Analysis
30.2.5. Cara Therapeutics Inc. Overview, Products and Services, Strategy and Financial Analysis
31. Kidney Fibrosis Treatment Market Other Major And Innovative Companies
31.1. Gilead Sciences Inc.
31.2. Novo Nordisk A/S
31.3. Boehringer Ingelheim International GmbH
31.4. Vertex Pharmaceuticals Incorporated
31.5. Chinook Therapeutics Inc.
31.6. Reata Pharmaceuticals Inc.
31.7. Akebia Therapeutics Inc.
31.8. Travere Therapeutics Inc.
31.9. Insilico Medicine Inc.
31.10. Tvardi Therapeutics Inc.
31.11. ProKidney LLC
31.12. Alentis Therapeutics AG
31.13. La Jolla Pharmaceutical Company
31.14. Galecto Biotech AB
31.15. Purespring Therapeutics Inc.
32. Global Kidney Fibrosis Treatment Market Competitive Benchmarking And Dashboard
33. Key Mergers And Acquisitions In The Kidney Fibrosis Treatment Market
34. Recent Developments In The Kidney Fibrosis Treatment Market
35. Kidney Fibrosis Treatment Market High Potential Countries, Segments and Strategies
35.1 Kidney Fibrosis Treatment Market In 2029 - Countries Offering Most New Opportunities
35.2 Kidney Fibrosis Treatment Market In 2029 - Segments Offering Most New Opportunities
35.3 Kidney Fibrosis Treatment Market In 2029 - Growth Strategies
35.3.1 Market Trend Based Strategies
35.3.2 Competitor Strategies
36. Appendix
36.1. Abbreviations
36.2. Currencies
36.3. Historic And Forecast Inflation Rates
36.4. Research Inquiries
36.5. The Business Research Company
36.6. Copyright And Disclaimer
How Do Licenses Work?
Head shot

Questions or Comments?

Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.